Athanassios Argiris
Investigator
Oncology
BRFAA
Greece
Biography
He received his medical degree from the University of Athens Medical School. He is currently an Adjunct Professor at University of Texas and was elected Visiting Professor at the University of Crete in 2011. Dr. Argiris is the founding president of the Hellenic Society of Head and Neck Oncology (HeSHNO). He is also a member of several international oncology organizations, including the Eastern Cooperative Oncology Group (ECOG), SWOG, European Organization for Research and Treatment of Cancer, American Society of Clinical Oncology (ASCO), and ESMO.
Research Interest
His research interest focus on focuses on the development of targeted and personalized therapies for head and neck cancers, as well as lung cancers.
Publications
-
A. Argiris, M.V. Karamouzis, W.E. Gooding, B.F. Branstetter, S. Zhong, L.E. Raez, P. Savvides, M. Romkes. “Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer†Journal of Clinical Oncology 2011;29:1140-45
-
A. Argiris, Y. Li, A. Forastiere. “Prognostic factors and long-term survivorship in patients with recurrent or metastatic head and neck cancer: an analysis of two Eastern Cooperative Oncology Group randomized trials†Cancer 2004;101:2222-9
-
A. Argiris , B.E. Brockstein, D.J. Haraf, K.M. Stenson, B.B. Mittal, M.S. Kies, F.R. Rosen, B. Jovanovic, E.E.Vokes.“Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy†Clinical Cancer Research 2004;10:1956-62
